The mAb HCA2 reacts preferentially with HLA-A locus heavy chains. Its reactivity contrasts
with that of HC1O, a mAb with more pronounced specificity for HLA-B and-C heavy chains …

The expression of MHC class‐I antigens was analysed in 67 cervical carcinoma biopsies;
16% of the biopsies showed complete or heterogeneous loss of HLA expression as judged …

Controversy exists regarding major histocompatibility complex antigen expression on
hepatocytes. In this study, hepatocyte expression of class I and II major histocompatibility …

The pathogenic mechanism leading to liver tissue injury in hepatitis caused by hepatitis A
virus is unclear. We have randomly established T-cell clones from liver biopsies from four …

To evaluate the impact of MHC antigen expression on the survival of patients with cancer, 77
human breast carcinomas were investigated for the expression of beta 2-microglobulin (beta …

The expression of the major histocompatibility complex (MHC) class I and II antigens and
lymphocyte function-associated antigen-3 (LFA-3) was investigated using …

We examined immunohistologically the expression of major histocompatibility complex
(MHC) class I and II antigens, which play important roles in immune reactions, on transitional …

In 70 human carcinomas of the lung the expression of histocompatibility antigens (HLA) was
investigated by using monoclonal antibodies in frozen sections. The immunoreactive tumor …

The rejection of tumor cells by the immune system depends on the production of tumor-
associated antigens and the expression of HLA antigens on these cells. We therefore …

• For therapeutic or diagnostic use of monoclonal antibodies in clinical oncology, high-
affinity IgG antibodies to tumorassociated antigens have to be generated. In order to find out …